Literature DB >> 9819693

Postoperative hospital-acquired infection in Hungvuong Obstetric and Gynaecological Hospital, Vietnam.

T S Tran1, S Jamulitrat, V Chongsuvivatvong, A Geater.   

Abstract

A prospective study was conducted following 1364 major operations at the 450-bed Hungvuong Obstetric and Gynaecological Hospital in HoChiMinh City, Vietnam, from 1 May to 30 September 1997 to characterize postoperative hospital-acquired infections. These infections were identified by ward rounds, review of laboratory results and patient follow-up until 30 days after discharge. During the study period, 194 infections were identified, yielding a rate of 14.2 infections per 100 operations. The most common sites were surgical wound and urinary tract, contributing together 95.9% of all hospital-acquired infections. The four most common pathogens were Staphylococcus aureus (29.6%), Escherichia coli (20.4%), Enterococci (16.7%) and Staphylococcus epidermidis (14.8%).

Entities:  

Mesh:

Year:  1998        PMID: 9819693     DOI: 10.1016/s0195-6701(98)90093-7

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

1.  A prospective study on bacteriological profile and antibiogram of postoperative wound infections in a tertiary care hospital in Western Rajasthan.

Authors:  Himanshu Narula; Gaurav Chikara; Pratima Gupta
Journal:  J Family Med Prim Care       Date:  2020-04-30

2.  The management of Staphylococcus aureus bacteremia in the United Kingdom and Vietnam: a multi-centre evaluation.

Authors:  Guy E Thwaites
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

3.  Incidence and risk factors for surgical site infections in obstetric and gynecological surgeries from a teaching hospital in rural India.

Authors:  Ashish Pathak; Kalpana Mahadik; Manmat B Swami; Pulak K Roy; Megha Sharma; Vijay K Mahadik; Cecilia Stålsby Lundborg
Journal:  Antimicrob Resist Infect Control       Date:  2017-06-14       Impact factor: 4.887

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.